- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Co-use of Cannabis Edibles and Alcohol Increases Driving Impairment, suggests JAMA study

According to new research, combining cannabis edibles with alcohol significantly worsened driving performance and increased feelings of intoxication compared with using either substance alone. The combined use led to greater cognitive and behavioral impairment, raising concerns about road safety. Previous research had mainly examined smoked or inhaled cannabis, while this study highlighted similar risks with edible cannabis products as well. The study was published in JAMA Network Open by C Austin Z. and colleagues.
In order to separate the effect of each substance on its own and when used simultaneously, a rigorous within-subjects design was chosen that involved a double-blind, double-dummy crossover. The study was carried out from February 2022 through August 2025. The sample involved healthy participants who had been recently engaging in binge drinking and co-ingesting the tested drugs, albeit less frequently than three days per week. In total, all subjects participated in seven different outpatient trials, with each trial separated by a week-long washout interval for ensuring complete elimination of the active drug components. Dietary manipulations included brownies that contained 0 mg, 10 mg, and 25 mg of Delta-9-tetrahydrocannabinol.
Additionally, the brownies were combined with placebo beverages or alcoholic drinks adjusted so that the Breath Alcohol Concentration (BrAC) would be 0.00%, 0.05%, and 0.08% correspondingly. Main outcome measures were evaluated by means of simulated driving test through the Global Drive Score (GDS), an aggregated measurement of multiple aspects of driving ability, and standard deviation of lateral position. Secondary endpoints included measurements of cumulative number of impairment clues using SFSTs, subjective intoxication, cognitive performance via the DRUID mobile application, and successive blood cannabinoid concentrations.
Key findings:
- The experiment succeeded in testing 25 healthy volunteers who included 15 men (60.0%) and 10 women (40.0%), with a mean age of 25.6 years (±4.9 years).
- All active drug use cases except for the single case of the 10 mg of THC resulted in impairment to the global drive score (GDS).
- The alcohol-induced driving impairment in the case of a 0.08% BrAC level was equal to the combination of 0.05% BrAC with 10 mg of THC in terms of mean GDS (1.6 ±1.6 vs. 1.4 ±1.4, respectively).
- At a 0.05% BrAC with 25 mg of THC edible consumption, the mean GDS sharply increased to 2.5 (±1.7), making a significant impact that exceeded the effect of the legal amount of alcohol consumption by far (P = .02).
- In comparison with placebo, the SFST performance was significantly worse at 0.08% BrAC, resulting in mean SFST score reaching 2.2 ±2.2 (from 0.2 ±1.3 under placebo; P = .008).
- SFST did not show significant deterioration in many cases when the driving skills were severely impaired during simulation.
This cross-over study demonstrates that the combination of cannabis edibles and alcohol dramatically increases impairment while driving, rendering the standard legal limit of 0.08% BrAC extremely hazardous for users. Given the growing number of recreational cannabis shops opening up and the increasing popularity of cannabis oral edibles, it is important to have laws in place which account for co-use by individuals. In such circumstances, legislators and traffic safety authorities can use these findings to reassess existing regulations and set up lower limits of BrAC.
Reference:
Zamarripa, C. A., Lin, S., Klausner, M., Rastogi, K., Roche, D. J. O., Novak, M., Antoine, D., Wolinsky, D., Marcotte, T. D., Weerts, E. M., Vandrey, R., & Spindle, T. R. (2026). Impact of Cannabis Edibles Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective Effects: A Within-Participant Crossover Trial. JAMA network open, 9(5), e269842. https://doi.org/10.1001/jamanetworkopen.2026.9842
Dr Riya Dave has completed dentistry from Gujarat University in 2022. She is a dentist and accomplished medical and scientific writer known for her commitment to bridging the gap between clinical expertise and accessible healthcare information. She has been actively involved in writing blogs related to health and wellness.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

